Source
Technologynetworks Biopharma
Gene therapy eliminated pain and improved blood counts in most patients with sickle cell disease in a major trial.
New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few curative options.
News Url